Phase II evaluation of maytansine in patients with metastatic lung cancer

Cancer Treat Rep. 1978 Oct;62(10):1577-9.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adult
  • Aged
  • Carcinoma / drug therapy
  • Drug Evaluation
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Maytansine / adverse effects
  • Maytansine / therapeutic use*
  • Middle Aged
  • Neoplasm Metastasis
  • Oxazines / therapeutic use*

Substances

  • Oxazines
  • Maytansine